News
Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
11 Mar 24
Analyst Ratings
Needham Reiterates Buy on Nurix Therapeutics, Maintains $31 Price Target
11 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Nurix Therapeutics Says FDA Lifts Partial Clinical Hold On NX-2127 Phase 1 Trial
11 Mar 24
News, FDA
Morgan Stanley Maintains Equal-Weight on Nurix Therapeutics, Raises Price Target to $10
26 Feb 24
News, Price Target, Analyst Ratings
Decoding 4 Analyst Evaluations For Nurix Therapeutics
16 Feb 24
Analyst Ratings
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $22
16 Feb 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Nurix Therapeutics, Maintains $31 Price Target
16 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on Nurix Therapeutics, Maintains $31 Price Target
2 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Nurix Therapeutics Announces Publication In Journal Science Titled: "Kinase Impaired BTK Mutations Are Susceptible to Clinical Stage BTK and IKZF1/3 Degrader NX-2127"
1 Feb 24
Biotech, News, General
Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
28 Dec 23
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Press releases
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
11 Mar 24
Press Releases
Nurix Therapeutics to Participate in Upcoming Investor Conferences
6 Mar 24
News, Press Releases
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
15 Feb 24
Earnings, Press Releases
Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader
1 Feb 24
Health Care, Analyst Ratings, Press Releases
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL
16 Jan 24
Health Care, Press Releases, General
Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
2 Jan 24
News, Press Releases